Elan Corp. PLC ADS (NY: ELN)
Last Price  /  Updated: 6:40 PM EST, Dec 18, 2013  /  Add to My Watchlist      
(ELN) Community Analysis from
April 19, 2014
(Stock Blog Hub, 8/15/13)
Elan Corporation (ELN) recently provided an update on its strategic plans for the future. The company plans several acquisitions and has other strategic initiatives lined up for further...(read more)
(Wealth Daily, 7/30/13)
The biotech industry is primed for an outstanding year. Most recently, U.S. company Perrigo (NYSE: PRGO) agreed to purchase Ireland's Elan Corp. (NYSE: ELN)...
(Stock Blog Hub, 4/27/13)
Elan Corporation’s (ELN) Board of Directors recently responded to Echo Pharma Acquisition Limited’s (“Royalty Pharma”) offer to acquire Elan's shares under Rule 2.5 of the...(read more)
Elan Corporation (ELN) Company Overview

Elan Corporation (NYSE:ELN) is a biotechnology company that makes drugs to treat Alzheimer’s disease, multiple sclerosis, Crohn’s disease and severe bacterial infections.[1]

(Read more at Wikinvest )

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here